CTI BioPharma (CTIC) Reports Q3 Loss of $0.28
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q3 EPS of ($0.28), versus ($1.04) reported last year.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
